Apellis Pharmaceuticals, Inc. (APLS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Apellis Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 141.40x | -19.98x | -13.44x | -8.41x | -5.35x | -12.47x |
| P/B Ratio | 8.55x | 17.30x | 36.52x | 32.30x | 20.09x | 21.02x |
| P/S Ratio | 3.15x | 5.06x | 17.91x | 72.75x | 59.96x | 17.15x |
| Profitability | ||||||
| Gross Margin | 89.8% | 84.9% | 85.2% | 92.5% | 92.2% | 90.0% |
| Operating Margin | 5.5% | -21.1% | -130.4% | -788.4% | -805.7% | -85.3% |
| Net Margin | 2.2% | -25.3% | -133.3% | -864.7% | -1121.3% | -137.6% |
| EBITDA Margin | 7.0% | -19.8% | -124.9% | -818.6% | -1098.6% | -124.6% |
| Liquidity | ||||||
| Current Ratio | 3.14x | 4.25x | 3.10x | 4.29x | 6.25x | 7.15x |
| Quick Ratio | 2.70x | 3.81x | 2.50x | 3.78x | 6.07x | 7.15x |
| Leverage | ||||||
| Debt/Equity | 1.31x | 2.06x | 0.57x | 0.66x | 1.06x | 1.85x |
YoY = year-over-year change. Source: FMP..